163 related articles for article (PubMed ID: 25622187)
21. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
McLean S; Di Guglielmo GM
Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
[TBL] [Abstract][Full Text] [Related]
22. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
23. Regulated intramembrane proteolysis of the TGFβ type I receptor conveys oncogenic signals.
Gudey SK; Wallenius A; Landström M
Future Oncol; 2014 Aug; 10(11):1853-61. PubMed ID: 24597658
[TBL] [Abstract][Full Text] [Related]
24. Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis.
Lin Y; Qiu Y; Xu C; Liu Q; Peng B; Kaufmann GF; Chen X; Lan B; Wei C; Lu D; Zhang Y; Guo Y; Lu Z; Jiang B; Edgington TS; Guo F
J Natl Cancer Inst; 2014 Apr; 106(4):dju012. PubMed ID: 24610907
[TBL] [Abstract][Full Text] [Related]
25. Non-Smad signaling pathways.
Mu Y; Gudey SK; Landström M
Cell Tissue Res; 2012 Jan; 347(1):11-20. PubMed ID: 21701805
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
27. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
28. TRAF6 upregulates expression of HIF-1α and promotes tumor angiogenesis.
Sun H; Li XB; Meng Y; Fan L; Li M; Fang J
Cancer Res; 2013 Aug; 73(15):4950-9. PubMed ID: 23722539
[TBL] [Abstract][Full Text] [Related]
29. Generation of mice with conditionally activated transforming growth factor beta signaling through the TbetaRI/ALK5 receptor.
Bartholin L; Cyprian FS; Vincent D; Garcia CN; Martel S; Horvat B; Berthet C; Goddard-Léon S; Treilleux I; Rimokh R; Marie JC
Genesis; 2008 Dec; 46(12):724-31. PubMed ID: 18821589
[TBL] [Abstract][Full Text] [Related]
30. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
31. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K(63) -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6.
Singh AK; Umar S; Riegsecker S; Chourasia M; Ahmed S
Arthritis Rheumatol; 2016 Feb; 68(2):347-58. PubMed ID: 26473505
[TBL] [Abstract][Full Text] [Related]
33. Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit.
Taniguchi A; Matsuzaki K; Nakano K; Kan M; McKeehan WL
In Vitro Cell Dev Biol Anim; 1998 Mar; 34(3):232-8. PubMed ID: 9557941
[TBL] [Abstract][Full Text] [Related]
34. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
[TBL] [Abstract][Full Text] [Related]
35. Conserved role for 14-3-3epsilon downstream of type I TGFbeta receptors.
McGonigle S; Beall MJ; Feeney EL; Pearce EJ
FEBS Lett; 2001 Feb; 490(1-2):65-9. PubMed ID: 11172812
[TBL] [Abstract][Full Text] [Related]
36. Sterol Regulatory Element Binding Protein (SREBP)-1 is a novel regulator of the Transforming Growth Factor (TGF)-β receptor I (TβRI) through exosomal secretion.
Van Krieken R; Chen G; Gao B; Read J; Al Saleh HA; Li R; Al-Nedawi K; Krepinsky JC
Cell Signal; 2017 Jan; 29():158-167. PubMed ID: 27826032
[TBL] [Abstract][Full Text] [Related]
37. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
Jakus PB; Kalman N; Antus C; Radnai B; Tucsek Z; Gallyas F; Sumegi B; Veres B
J Nutr Biochem; 2013 May; 24(5):819-23. PubMed ID: 22925919
[TBL] [Abstract][Full Text] [Related]
38. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.
Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X
Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197
[TBL] [Abstract][Full Text] [Related]
39. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
[TBL] [Abstract][Full Text] [Related]
40. Binding of coronin 1B to TβRI negatively regulates the TGFβ1 signaling pathway.
Kim GY; Lim HJ; Park HY
Biochem Biophys Res Commun; 2017 Aug; 490(2):574-579. PubMed ID: 28625921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
